WHO's new HIV guidelines call for antiretroviral therapy for all patients

New World Health Organization (WHO) guidelines recommend that antiretroviral therapy (ART) be administered to any patient with HIV -- even those whose immune systems have not yet been compromised (based on the CD4 cell count in the bloodstream).

WHO also recommendeds the use of daily oral pre-exposure prophylaxis (PrEP) for those at higher risk of HIV infection, including commercial sex workers, gay men and intravenous drug users.

"These timely recommendations will make it easier for the poorest and most vulnerable populations everywhere to access the best treatment and services that modern science can provide and that are already available in the world’s richest countries,” Lelio Marmora, executive director of the global health organization UNITAID.

Following the new WHO guidlelines, it is estimated, could prevent 21 million deaths and 28 million new infections by 2030.

Late last week, WHO representatives, in conjunction with the United Nations, set a goal to end the worldwide AIDS pandemic by 2030.

UNITAID, in partnership with health partners, plans to finance HIV and AIDS prevention programs in Latin America, Asia and Africa to launch the WHO strategy among vulnerable populations.

Organizations in this Story


Want to get notified whenever we write about Unitaid ?
Next time we write about Unitaid, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.